Related references
Note: Only part of the references are listed.Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial
Joseph A. Politch et al.
PLOS MEDICINE (2021)
Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women
Gabriela Baldeon-Vaca et al.
EBIOMEDICINE (2021)
The postcoital test in the development of new vaginal contraceptives
Christine K. Mauck et al.
BIOLOGY OF REPRODUCTION (2020)
Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices
Ashlyn H. Savage et al.
OBSTETRICS AND GYNECOLOGY (2018)
There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes
Chelsea B. Polis et al.
REPRODUCTIVE HEALTH (2018)
One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception
J. N. Sanders et al.
CONTRACEPTION (2017)
A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gel
Christine K. Mauck et al.
CONTRACEPTION (2017)
Declines in Unintended Pregnancy in the United States, 2008-2011
Lawrence B. Finer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial
G. Justus Hofmeyr et al.
REPRODUCTIVE HEALTH (2016)
Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity
Andrea Ries Thurman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
Melis N. Anahtar et al.
IMMUNITY (2015)
Contraceptive Efficacy, Safety, Fit, and Acceptability of a Single-Size Diaphragm Developed With End-User Input
Jill L. Schwartz et al.
OBSTETRICS AND GYNECOLOGY (2015)
Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates
Irina A. Zalenskaya et al.
PLOS ONE (2015)
A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation
Raina N. Fichorova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception
Raina N. Fichorova et al.
MBIO (2015)
Long-term ongoing pregnancy rate and mode of conception after a positive and negative post-coital test
Marloes Hessel et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2014)
Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
Jacques Ravel et al.
MBIO (2012)
Postcoital test: which form of spermatozoal motility is associated with a good fertility outcome?
B. C. Dunphy et al.
ANDROLOGIA (2010)
World Health Organization reference values for human semen characteristics
Trevor G. Cooper et al.
HUMAN REPRODUCTION UPDATE (2010)
Contraceptive Efficacy, Acceptability, and Safety of C31G and Nonoxynol-9 Spermicidal Gels A Randomized Controlled Trial
Anne E. Burke et al.
OBSTETRICS AND GYNECOLOGY (2010)
Unintended Pregnancy: Worldwide Levels, Trends, and Outcomes
Susheela Singh et al.
STUDIES IN FAMILY PLANNING (2010)
SILCS diaphragm: postcoital testing of a new single-size contraceptive device
Jill L. Schwartz et al.
CONTRACEPTION (2008)
Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis
Erika V. Valore et al.
INFECTION AND IMMUNITY (2006)
Effect of long-term use of nonoxynol-9 on vaginal flora
CA Schreiber et al.
OBSTETRICS AND GYNECOLOGY (2006)
In vitro and in vivo - The story of Nonoxynol 9
SL Hillier et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
A Phase I comparative postcoital testing study of three concentrations of C31G
CK Mauck et al.
CONTRACEPTION (2004)
Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product
E Amaral et al.
CONTRACEPTION (2004)
Disruption of the upper female reproductive tract epithelium by nonoxynol-9
MB Dayal et al.
CONTRACEPTION (2003)
Epitope analysis for human sperm-immobilizing monoclonal antibodies, MAb H6-3C4, 1G12 and campath-1
A Hasegawa et al.
MOLECULAR HUMAN REPRODUCTION (2003)
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers:: a randomised controlled trial
L Van Damme et al.
LANCET (2002)
The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission
RN Fichorova et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
The prognostic power of the post-coital test for natural conception depends on duration of infertility
CMA Glazener et al.
HUMAN REPRODUCTION (2000)
Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers
L Van Damme et al.
AIDS (2000)
Share Paper
